i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
Advanced Pharmacology Psychopharmacology for the i,- i,- i,- i,- i,-
Psychiatric-Mental Health Nurse Practitioner | i,- i,- i,- i,- i,-
Questions with Verified Answers – Chamberlain. i,- i,- i,- i,- i,-
How does reviewing the genetic makeup of a client help guide
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
the PMHNP in selecting medication for clients?
i,- -Genetic i,- i,- i,- i,- i,- i,-i,- i,- i,-
testing can assist by providing more information on how clients
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
may respond to certain psychotropic medications
i,- i,- i,- i,- i,-
-provides information on how a client may break down and
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
metabolize medications based on the cytochrome P450 system.
i,- i,- i,- i,- i,- i,- i,-
Tanrıkulu and Erbaş (2020) investigated identical twins to
i,- i,- i,- i,- i,- i,- i,- i,-
determine the presence of an inherited link for schizophrenia and
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
why one twin may develop schizophrenia when the other does
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
not. When two people have 100% identical DNA, why don't both
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
persons develop the exact illnesses? Studies of identical Danish
i,- i,- i,- i,- i,- i,- i,- i,- i,-
twins found that if one twin had schizophrenia, the other twin
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
had a 50% lifetime risk of developing schizophrenia (Lemvigh et
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
al., 2020). Why is there only half the risk?
i,- i,-Both environmental i,- i,- i,- i,- i,- i,- i,-i,- i,- i,- i,-
and psychosocial stressors can impact mental health. Although
i,- i,- i,- i,- i,- i,- i,- i,-
twins may have identical genes, their gene expression may be
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
different.
, There may be an environmental exposure that turned a gene "on"
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
that should have been "off" for one twin to develop
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
schizophrenia and not the other. i,- i,- i,- i,-
What should the PMHNP consider when prescribing chemical
i,- i,- i,- i,- i,- i,- i,- i,-
restraints? -allergy status i,-i,- i,- i,-
-prior med hx for adverse drug reactions r/t the meds ordered in
i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,- i,-
the chemical restraint
i,- i,-
-state regulations regarding chemical restrains must be reviewed
i,- i,- i,- i,- i,- i,- i,-
central sulcus i,- i,-i,- i,- separates the frontal lobe from the parietal lobe
i,- i,- i,- i,- i,- i,- i,-
frontal lobe i,- i,-i,- i,- associated with movement, intelligence, abstracti,- i,- i,- i,- i,-
thinking
broca's area i,- i,-i,- i,- speech production i,-
temporal lobe i,- i,-i,- i,- involves object identification and auditory
i,- i,- i,- i,- i,-
signals
cerebellum i,-i,- i,- coordination